D. E. Shaw & Co., Inc. Morphic Holding, Inc. Transaction History

D. E. Shaw & Co., Inc.

$114 Billion
Q1 2024

A detailed history of D. E. Shaw & Co., Inc. transactions in Morphic Holding, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 214,456 shares of MORF stock, worth $7.31 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

214,456

Previous 301,901 28.96%

Holding current value

$7.31 Million

Previous $8.72 Million 13.42%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$26.64 - $40.31 $2.33 Million - $3.52 Million	-87,445 Reduced 28.96%	214,456 $7.55 Million
Q4 2023 Feb 14, 2024	BUY	$19.95 - $31.0 $3.15 Million - $4.9 Million	157,943 Added 109.71%	301,901 $8.72 Million
Q3 2023 Nov 14, 2023	SELL	$21.33 - $59.42 $483,124 - $1.35 Million	-22,650 Reduced 13.59%	143,958 $3.3 Million
Q2 2023 Aug 14, 2023	BUY	$34.33 - $62.11 $3.66 Million - $6.62 Million	106,592 Added 177.61%	166,608 $9.55 Million
Q1 2023 May 15, 2023	BUY	$26.01 - $48.69 $931,496 - $1.74 Million	35,813 Added 147.97%	60,016 $2.26 Million

Q4 2022 Feb 14, 2023	SELL	$24.14 - $30.37 $517,875 - $651,527	-21,453 Reduced 46.99%	24,203 $647,000
Q3 2022 Nov 14, 2022	BUY	$22.23 - $33.37 $160,100 - $240,330	7,202 Added 18.73%	45,656 $1.29 Million
Q2 2022 Aug 15, 2022	BUY	$19.74 - $43.01 $532,545 - $1.16 Million	26,978 Added 235.08%	38,454 $834,000
Q1 2022 May 16, 2022	SELL	$36.25 - $52.02 $518,375 - $743,886	-14,300 Reduced 55.48%	11,476 $461,000
Q4 2021 Feb 14, 2022	SELL	$43.27 - $65.72 $1.19 Million - $1.81 Million	-27,480 Reduced 51.6%	25,776 $1.22 Million
Q3 2021 Nov 15, 2021	SELL	$53.61 - $67.5 $2.05 Million - $2.59 Million	-38,305 Reduced 41.84%	53,256 $3.02 Million
Q2 2021 Aug 16, 2021	SELL	$45.13 - $64.99 $1.68 Million - $2.42 Million	-37,254 Reduced 28.92%	91,561 $5.26 Million
Q1 2021 May 17, 2021	BUY	$29.77 - $84.85 $2.21 Million - $6.31 Million	74,373 Added 136.61%	128,815 $8.15 Million
Q4 2020 Feb 16, 2021	BUY	$25.66 - $34.55 $400,142 - $538,772	15,594 Added 40.14%	54,442 $1.83 Million
Q3 2020 Nov 16, 2020	SELL	$22.51 - $30.11 $78,942 - $105,595	-3,507 Reduced 8.28%	38,848 $1.06 Million
Q2 2020 Aug 14, 2020	SELL	$12.65 - $29.57 $20,265 - $47,371	-1,602 Reduced 3.64%	42,355 $1.15 Million
Q1 2020 May 15, 2020	BUY	$10.84 - $20.85 $476,493 - $916,503	43,957 New	43,957 $645,000

Others Institutions Holding MORF

# of Institutions

142

Shares Held

37.9M

Call Options Held

13.5K

Put Options Held

190K

View Full List

About Morphic Holding, Inc.

Ticker MORF
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 38,477,100
Market Cap $1.31B
Description
Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...

More about MORF

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account